Upsher-Smith's antiepileptic drug Qudexy XR gets FDA approval

Upsher-Smith Laboratories (Upsher-Smith) has secured approval from the US Food and Drug Administration (FDA) for Qudexy XR (topiramate) extended-release capsules, indicated as initial monotherapy in patients ten years or older with partial-onset seiz…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news